Skip to main content

AI Spots Early Esophageal Cancer on Routine CT Scans

Alibaba's DAMO Academy has rolled out its fourth cancer-screening AI, and this one tackles a tough target: esophageal cancer. Dubbed DAMO EAGLE, the model reads plain CT scans—no endoscopy, no contrast dye—and flags early-stage tumors and precancerous lesions. Developed with Sichuan Cancer Hospital and Sun Yat-sen University Cancer Center, it was validated on 80,000 cases across three countries. The paper appeared in Nature Medicine on September 22.

Why this is a big deal

China shoulders nearly half the world's esophageal cancer cases and deaths. Most patients find out too late, when curative treatment is off the table. Catch it early, though, and minimally invasive surgery can cure over 95% of cases. The problem? The gold-standard screening—upper endoscopy—is invasive, costly, and hard to scale. Plain chest CT, on the other hand, is cheap, quick, and already used for lung cancer screening. Its scan range naturally covers the esophagus. So why not let AI spot esophageal trouble while it's checking the lungs?

Easier said than done. The esophagus is a long, floppy tube that collapses easily. Early lesions hide in thin mucosal layers, and the heart's constant beating blurs the picture. Radiologists struggle to see anything suspicious on plain CT.

How they cracked it

Yao Jiawen, an algorithm expert at DAMO Academy, explains the trick: the team matched endoscopic reports with precise lesion locations on contrast-enhanced CT, then mapped those onto plain CT images. That taught the AI to pick up early signs the human eye misses.

Image

The numbers speak. In opportunistic screening, DAMO EAGLE hit 90% sensitivity for esophageal cancer—meaning it rarely misses a case. For very faint precancerous signals, sensitivity was 52.5%. In real-world settings, specificity (avoiding false alarms) reached 99.2%. And it held up on low-dose CT, so it can slot right into existing lung cancer screening without extra radiation or patient hassle.

What doctors are saying

Dr. Wang Qifeng, chief physician at Sichuan Cancer Hospital's Radiotherapy Department, points to local habits—hot, salty foods—that make esophageal cancer common in western China, especially Sichuan. Endoscopy screening lags badly due to limited resources and poor patient compliance. "AI isn't replacing endoscopy," Wang says. "It's identifying high-risk people who then get endoscopy. That makes the exam more targeted and boosts detection rates." More importantly, it pushes prevention earlier, when there's still time.

The bigger picture

With models for pancreatic, gastric, colorectal, and esophageal cancers plus aortic dissection already out, DAMO Academy has stitched together a "plain CT + AI" multi-check route. Five papers in Nature Medicine. The potential: screen for China's top seven deadly cancers from a single plain CT scan.

Key Points:

  • DAMO EAGLE detects early esophageal cancer from plain CT—no endoscopy or contrast needed.
  • Validated on 80,000 cases in three countries; published in Nature Medicine.
  • Achieves 90% sensitivity and 99.2% specificity; works on low-dose CT.
  • Designed to complement, not replace, endoscopy by flagging who needs it.
  • Part of a broader push to screen multiple cancers with one routine scan.